| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.554 | 22.320 | 25.756 | 23.882 | 20.395 | 14.729 | 32.133 | 24.639 | 25.052 | 32.241 |
| Total Income - EUR | 22.061 | 22.333 | 25.754 | 24.266 | 20.395 | 14.729 | 32.153 | 24.690 | 25.117 | 32.284 |
| Total Expenses - EUR | 14.315 | 16.292 | 13.468 | 12.499 | 11.131 | 11.478 | 12.031 | 11.078 | 13.353 | 18.168 |
| Gross Profit/Loss - EUR | 7.746 | 6.042 | 12.286 | 11.767 | 9.264 | 3.251 | 20.122 | 13.612 | 11.764 | 14.116 |
| Net Profit/Loss - EUR | 7.085 | 5.595 | 11.646 | 11.524 | 9.060 | 3.103 | 19.800 | 13.365 | 11.513 | 13.223 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Med-Gnosa Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.203 | 10.081 | 7.503 | 5.907 | 4.309 | 1.590 | 270 | 0 | 0 | 0 |
| Current Assets | 16.009 | 5.514 | 13.360 | 8.732 | 12.998 | 15.662 | 22.518 | 16.242 | 12.908 | 14.567 |
| Inventories | 0 | 0 | 849 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.632 | 2.466 | 2.573 | 2.046 | 2.232 | 1.776 | 3.858 | 3.502 | 2.767 | 0 |
| Cash | 14.378 | 3.048 | 9.938 | 6.686 | 10.766 | 13.886 | 18.660 | 12.740 | 10.140 | 14.567 |
| Shareholders Funds | 18.133 | 5.649 | 17.199 | 11.576 | 14.090 | 12.683 | 19.849 | 13.414 | 11.561 | 13.271 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.080 | 9.947 | 3.664 | 3.064 | 3.216 | 4.570 | 2.940 | 2.829 | 1.346 | 1.296 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6290 - 6290" | |||||||||
| CAEN Financial Year |
6209
|
|||||||||
Comments - Med-Gnosa Consult Srl